164 related articles for article (PubMed ID: 21386950)
21. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
Chappell AS; Littlejohn G; Kajdasz DK; Scheinberg M; D'Souza DN; Moldofsky H
Clin J Pain; 2009 Jun; 25(5):365-75. PubMed ID: 19454869
[TBL] [Abstract][Full Text] [Related]
22. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
[TBL] [Abstract][Full Text] [Related]
23. A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.
Chappell AS; Bradley LA; Wiltse C; Detke MJ; D'Souza DN; Spaeth M
Int J Gen Med; 2008 Nov; 1():91-102. PubMed ID: 20428412
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
25. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.
Choy EH; Mease PJ; Kajdasz DK; Wohlreich MM; Crits-Christoph P; Walker DJ; Chappell AS
Clin Rheumatol; 2009 Sep; 28(9):1035-44. PubMed ID: 19533210
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine: in patients with fibromyalgia.
Curran MP
Drugs; 2009 Jun; 69(9):1217-27. PubMed ID: 19537838
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
Russell JI; Mease PJ; Smith TR; Kajdasz DK; Wohlreich MM; Detke MJ; Walker DJ; Chappell AS; Arnold LM
Pain; 2008 Jun; 136(3):432-444. PubMed ID: 18395345
[TBL] [Abstract][Full Text] [Related]
28. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
[TBL] [Abstract][Full Text] [Related]
29. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan.
Yasuda H; Hotta N; Nakao K; Kasuga M; Kashiwagi A; Kawamori R
J Diabetes Investig; 2011 Apr; 2(2):132-9. PubMed ID: 24843472
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
31. Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine.
Zilliox L; Russell JW
Diabetes Metab Syndr Obes; 2010 Jan; 3():7-17. PubMed ID: 21437071
[TBL] [Abstract][Full Text] [Related]
32. New treatment options for fibromyalgia: critical appraisal of duloxetine.
Uçeyler N; Offenbächer M; Petzke F; Häuser W; Sommer C
Neuropsychiatr Dis Treat; 2008 Jun; 4(3):525-9. PubMed ID: 18830399
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee.
Brown JP; Boulay LJ
Ther Adv Musculoskelet Dis; 2013 Dec; 5(6):291-304. PubMed ID: 24294303
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled, double-blinded trial of duloxetine in the treatment of general fatigue in patients with chronic fatigue syndrome.
Arnold LM; Blom TJ; Welge JA; Mariutto E; Heller A
Psychosomatics; 2015; 56(3):242-53. PubMed ID: 25660434
[TBL] [Abstract][Full Text] [Related]
36. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of duloxetine for chronic pain conditions.
Mease PJ; Walker DJ; Alaka K
Pain Manag; 2011 Mar; 1(2):159-70. PubMed ID: 24646356
[TBL] [Abstract][Full Text] [Related]
38. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
39. [Duloxetine for chronic pain management: pharmacology and clinical use].
Masuda R; Itoh M; Suzuki T
Masui; 2013 Jul; 62(7):814-21. PubMed ID: 23905404
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
